Recovery article

CJC-1295 / Ipamorelin Protocol Guide - Path to Peptides

Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol. Growth Hormone Blend Weekly Protocol Guid

By Recovery & Performance Peptides Editorial Team Published January 22, 2026

Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.

Protocol Overview

CompoundCJC-1295 / Ipamorelin (CJC-1295 (no DAC) 5mg + Ipamorelin 5mg) CategoryGrowth Hormone Blend Vial Size10mg total (10,000mcg) Reconstitution2mL bacteriostatic water (5mg/mL) RouteSubcutaneous injection Frequency2–3x daily, 5 days/week

Reconstitution Instructions

Using 2mL of bacteriostatic water results in a concentration of 5mg/mL total blend. Always use sterile techniques.

Materials Needed

10mg total CJC-1295 / Ipamorelin vial (lyophilized powder)
2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
Sterile syringe and needle (18-22 gauge for drawing)
Alcohol swabs
Clean workspace

Step-by-Step Process

Preparation: Allow the CJC-1295 / Ipamorelin vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles.
Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.

Weekly Dosing Reference · research convention, not a validated dose

This blend contains CJC-1295 (no DAC) + Ipamorelin in a 1:1 ratio. The standard protocol uses 300–500mcg of total blend per injection, 2–3 times daily on an empty stomach. The bedtime dose is most important.

Protocol	Per Injection	Frequency	Daily Total	Weekly (5 days)
Standard	300mcg blend (6 units)	3x daily (AM, post-workout, before bed)	900mcg	4,500mcg
Moderate	300mcg blend (6 units)	2x daily (AM, before bed)	600mcg	3,000mcg
Beginner	300mcg blend (6 units)	1x daily (before bed)	300mcg	1,500mcg

Standard dose: 300–500mcg blend per injection, 2–3x daily on empty stomach • Vial Duration: ~11–33 days depending on protocol (10mg vial)

Quick Dosing Reference (at 5mg/mL blend)

Units (Ticks)	Total Blend (mcg)	~CJC-1295	~Ipamorelin
4	200	100mcg	100mcg
6	300	150mcg	150mcg
8	400	200mcg	200mcg
10	500	250mcg	250mcg
20	1,000	500mcg	500mcg

Administration Guidelines

Administer subcutaneously before bed on an empty stomach
Rotate injection sites between abdomen, thigh, and upper arm
Store reconstituted peptide refrigerated at 36-46F (2-8C)
Use reconstituted solution within 30 days
Never freeze reconstituted peptides
Document administration times and observations

Storage Requirements

State	Storage Conditions
Lyophilized (powder)	Room temperature or refrigerated, protect from light
Reconstituted	Refrigerated 36-46F (2-8C), use within 30 days

⚠ Before any use: human safety data is limited or absent for many of these compounds. Consult a licensed healthcare provider first — especially if you are pregnant or nursing, have a medical condition, or take other medications.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Understanding the Dosing for CJC-1295 With DAC

Now, let's pivot to the long-acting version. This is a completely different beast, and its protocol reflects that. Because of its incredibly long half-life (thanks to that Drug Affinity Complex), daily administration is not only unnecessary but also ill-advised. It would lead to a massive, unnatural buildup of the compound. Instead, research protocols for CJC-1295 with DAC typically use a weekly or bi-weekly schedule. A common dose ranges from 1,000 to 2,000 micrograms (1 to 2 milligrams) administered once per week. Think about that. You're going from 100 mcg multiple times a day to up to 2,000 mcg once a week. It’s a monumental difference. This approach doesn't create pulses. It creates a steady, elevated baseline of GH levels throughout the week. This “GH bleed” can be useful for certain research models where a constant elevation is desired over pulsatility. However, a significant portion of the research community has moved away from this method. Why? There's a prevailing theory that the body's natural pulsatile rhythm of GH release is crucial for optimal receptor signaling and to avoid desensitization. Constant stimulation, as provided by the DAC version, may not be as effective long-term as the more biomimetic approach of Mod GRF 1-29 paired with a GHRP. It's a fascinating area of study, and the choice between pulsatility and sustained elevation remains a key variable depending on the research goal.

Question drills

Open a question for its connected answer.

01What If You Experience Redness or Itching?+

It's not uncommon, especially when first starting, to notice a small, localized reaction at the injection site. This often presents as a red, slightly raised, or itchy welt, sometimes called a "histamine reaction." Ipamorelin, in particular, can sometimes cause this localized release of histamine. For the vast majority of cases, this is a minor and temporary reaction that subsides within an hour or two. It's generally not a sign of an allergy. However, if you experience widespread hives, difficulty breathing, or swelling of the face and throat, that would be indicative of a serious allergic reaction requiring immediate medical attention. A small, localized red spot is typically just part of the process. If it's bothersome, you can try injecting in a different area (like the glutes instead of the stomach) to see if the reaction is less pronounced. Many researchers find these minor reactions lessen or disappear entirely as their protocol continues.

SOURCE / realpeptides.co ↗

Product & matchup locker

Linked catalog and comparison files.

Comparison

Injection Method Comparison for Research

While CJC-1295 is almost exclusively used subcutaneously in research, understanding different administration routes provides broader context for laboratory work. Here's how they c…